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Background: The great majority of successfully resuscitated out-of-hos-
pital cardiac arrest (OHCA) patients will subsequently die during their ICU
and hospital stay. Several studies have previously described the main causes
of OHCA but the impact of aetiology on the outcome and the timing and value
of diagnostic procedures such as coronary angiogram remains controversial.
Methods: We analysed the causes of cardiac arrest in a prospective data-
base from a tertiary reference. We compared the mortality observed in the sub-
groups of patients with a cardiac or a non-cardiac cause of arrest.
Results: 983 patients were admitted from January 2000 to August 2008.In
patients without an obvious non-cardiac cause of arrest, a coronary angiogram
followed if necessary by a coronary angioplasty was performed at admission.
The median age was 58 years (range 84.39) and 74% were male. Past or cur-
rent cigarette smoking was noted in 54%, hypertension in 35% and hypercho-
lesterolemia in 23%. The causes of OHCA were an acute coronary syndrome
(ACS=Gr1) in 389 pts (40%), primary ventricular arrhythmia (VT-FV=Gr2) in
154 pts (16%), cardiac failure (=Gr3) in 35 pts (3%), acute respiratory failure
(=Gr4) in 186 pts (19%), neurological failure (=Gr5) in 41 pts (4%), unknown
(=Gr6) in 71 pts (7%) and others causes(=Gr7) in 104 pts (11%). Overall, the
mortality rate of the entire cohort was 68%; mortality rates observed in each
subgroup are displayed in the figure. 
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Introduction: Central venous oxygen saturation (SvO2) provides an accu-
rate assessment of oxygen delivery and organs consumption balance, and cor-
relate with outcome in extra cardiac shock. Its prognosis value has never been
specifically validated in heart failure patients with cardiogenic shock.
Methods: SvO2 was prospectively assessed in 27 patients (60±17 years, 17
male, LVEF=25±6%) admitted for heart failure with cardiogenic shock. SvO2
before and after 24 hours (24H SvO2) of intra-venous inotropic and diuretic
support in patients with cardiogenic shock was compared to control subject
with compensate heart failure (n=12) and to in hospital outcome (death and
heart transplant).
Results: During hospitalisation period, major cardiovascular event
occurred in 10 (36%) patients (6 deaths, 4 heart transplants). In patients with
cardiogenic shock, admission SvO2 was lower than in patients with compen-
sated heart failure (50±12, 66±6, 95% CI>58%) but increased after 24H of
treatment (50±12, 59±8, p=0.002). Importantly, improvement in Sv02 at 24H
(>58%, n=15) was associated with an excellent in hospital outcome (93%, 14/
15), while a persistently low ScvO2 at 24H (< 58%) correlated with the occur-
rence of major cardiac adverse outcome (75%, 9/12).
Furthermore, there was no difference regarding to clinical or echographical
features between event free and poor outcome groups.
Conclusion: Change in SvO2 under intra-venous inotropic and diuretic
treatment is a strong predictor of outcome in patients with cardiogenic shock. 
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Background: Type B aortic syndrome is one of the most life-threatening
aortic condition. The management of descending aortic diseases remains con-
troversial. The aim of this study was to compare the results of medical and
endovascular treatments of type B aortic syndromes.
Method: The medical records of patients with type B aortic syndrome
between 2000 and 2009 were retrospectively revised. Type B aortic syndromes
consisted of acute aortic dissection (n= 71), chronic aortic dissection (n=32),
aortic hematoma (n=27) or penetrating ulcers (n=4). Patients with traumatic
aortic ruptures were excluded. The population was divided into two groups.
Patients of group A were medically treated (n=76) and patients of group B
underwent endovascular management (n= 58). Short and long term outcomes
were compared. The median follow up was 28.5 months.
Results: Mean age was 66.3±11.6 years old. The sex ratio was 2.83 (Male/
Female).In group B, past history of type A aortic dissection were more frequent
(p<.05) and mean aortic diameter of the descending thoracic aorta was higher
(p<.0001). There were no other statically significant differences between the
two groups. Overall in-hospital mortality was 11.8% in group A and 8.6% in
group B (p=0.53). Overall survivals at one year were respectively 84.3% and
88% in group A and B (p=0.54). Overall survivals at five years were respec-
tively 72.4% and 81.1% in group A and B (p=0.2). However a significant dif-
ference in mortality appeared at nine years follow up, giving the advantage to
the endovascular treatment according to Kaplan-Meier estimates (p<0.05).
Conclusion: In hospital mortality and mild term results were not different
between the two groups. Long term results seemed to be better in the endovas-
cular group. These results suggest the potential interest of endovascular man-
agement of type B aortic syndrome particularly in term of long term survival.
This point has to be confirmed in larger populations and longer follow up.
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